1. Home
  2. HLMN vs BEAM Comparison

HLMN vs BEAM Comparison

Compare HLMN & BEAM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HLMN
  • BEAM
  • Stock Information
  • Founded
  • HLMN 1964
  • BEAM 2017
  • Country
  • HLMN United States
  • BEAM United States
  • Employees
  • HLMN N/A
  • BEAM N/A
  • Industry
  • HLMN Industrial Machinery/Components
  • BEAM Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • HLMN Consumer Discretionary
  • BEAM Health Care
  • Exchange
  • HLMN Nasdaq
  • BEAM Nasdaq
  • Market Cap
  • HLMN 2.2B
  • BEAM 1.8B
  • IPO Year
  • HLMN N/A
  • BEAM 2020
  • Fundamental
  • Price
  • HLMN $7.75
  • BEAM $17.41
  • Analyst Decision
  • HLMN Buy
  • BEAM Strong Buy
  • Analyst Count
  • HLMN 5
  • BEAM 11
  • Target Price
  • HLMN $11.25
  • BEAM $48.90
  • AVG Volume (30 Days)
  • HLMN 2.1M
  • BEAM 2.2M
  • Earning Date
  • HLMN 04-29-2025
  • BEAM 05-06-2025
  • Dividend Yield
  • HLMN N/A
  • BEAM N/A
  • EPS Growth
  • HLMN N/A
  • BEAM N/A
  • EPS
  • HLMN 0.09
  • BEAM N/A
  • Revenue
  • HLMN $1,481,633,000.00
  • BEAM $63,578,000.00
  • Revenue This Year
  • HLMN $5.53
  • BEAM N/A
  • Revenue Next Year
  • HLMN $4.44
  • BEAM $6.32
  • P/E Ratio
  • HLMN $82.67
  • BEAM N/A
  • Revenue Growth
  • HLMN 0.31
  • BEAM N/A
  • 52 Week Low
  • HLMN $6.64
  • BEAM $13.53
  • 52 Week High
  • HLMN $12.08
  • BEAM $35.25
  • Technical
  • Relative Strength Index (RSI)
  • HLMN 50.58
  • BEAM 43.14
  • Support Level
  • HLMN $6.64
  • BEAM $15.51
  • Resistance Level
  • HLMN $7.54
  • BEAM $20.90
  • Average True Range (ATR)
  • HLMN 0.32
  • BEAM 1.22
  • MACD
  • HLMN 0.10
  • BEAM -0.03
  • Stochastic Oscillator
  • HLMN 81.92
  • BEAM 35.25

About HLMN Hillman Solutions Corp.

Hillman Solutions Corp is a provider of hardware-related products and related merchandising services to retail markets in North America. The company sells its products to hardware stores, home centers, mass merchants, pet supply stores, and other retail outlets. Its product lines include thousands of small parts such as fasteners and related hardware items; threaded rod and metal shapes; keys and accessories; builder's hardware; personal protective equipment, such as gloves and eye-wear; and identification items, such as tags and letters, numbers, and signs. The segments of the group are Hardware and Protective Solutions, which is the key revenue-generating segment; Robotics and Digital Solutions; and Canada. It has a business presence in the US, Canada and Mexico.

About BEAM Beam Therapeutics Inc.

Beam Therapeutics Inc is a biotechnology company committed to creating a new class of precision genetic medicines based on its proprietary base editing technology, with a vision of providing lifelong cures to patients suffering from serious diseases. The company is focused on its programs in the hematology and genetic disease portfolios, which comprise different product candidates in its pipeline, such as BEAM-101, which is being developed to target Sickle Cell Disease, BEAM-302, a liver-targeting lipid nanoparticle, being developed to target Alpha-1 antitrypsin deficiency, and other drug candidates including BEAM-302, BEAM-103 & 104. The company views its operations and manages its business in one operating segment, operating exclusively in the United States.

Share on Social Networks: